Hosted on MSN6m
Report Reveals Billions Made from Generic Drug Price HikesA recent Federal Trade Commission report highlights a concerning trend in the pharmaceutical industry, where pharmacy benefit ...
UnitedHealth's CEO acknowledged discontent with the health care system, but quickly shifted the blame elsewhere.
Andrew Witty, UnitedHealth CEO, said the move will remove an excuse other players use to blame Optum Rx for high drug costs.
Pharmacy benefit managers actually "play a vital role in holding" sometimes-inflated prices down, said UHG CEO Andrew Witty ...
According to FTC’s latest report, units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly ...
UnitedHealth’s net income plummeted to its lowest level since 2019 amid hefty costs, including some from the Change ...
UnitedHealth Group has reported quarterly profits of $5.5 billion after tax in its first earnings release since the killing ...
In an investor call, Andrew Witty promised full transparency and 100% pass-through rebates for prescription drugs by 2028.
Our narrow economic moat rating for UnitedHealth Group reflects our generally narrow-moat view of the US health insurance and PBM industries that includes an unclear outlook for economic profitability ...
FTC: ‘Big 3’ Pharmacy Benefit Managers Engaged in Price Gouging, PBMs, UnitedHealth OptumRx, CVS Caremark Rx, Express Scripts ...
On the post-earnings call with analysts, Chief Executive Andrew Witty addressed the recent public backlash over high drug costs and transparency of coverage, particularly following killing of Brian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback